[Histonet] SOP share

[Jamal Rwaihi via Histonet]

Hi colleagues

I hope all are fine

Please share me the SOP for:

1.Leica ASP6025 Automatic Tissue Processor.

2.Tissue-Tek Prisma & Film Automated Slide Stainer & Film Coverslipper.

3.Leica IP C Inkjet Printer for Tissue Cassettes.

 

 

 

Best Regards,

 

 

Jamal M. Al Rowaihi

Al Borg Medical Laboratories I Anatomic Pathology Supervisor I Headquarters,
Jeddah, KSA I Phone: +966 12 670 0099 I Mobile +966 503629832

  www.alborglaboratories.com

 

___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

[Histonet] unsatisfactory Thin prep

[Jamal Rwaihi via Histonet]

Dear colleagues

I appreciate if some can share me their statistics in unsatisfactory
ThinPrep and what it's the best solution to reduce the amount of
unsatisfactory results.

 

 

 

Best Regards,

 

 

Jamal M. Al Rowaihi

Al Borg Medical Laboratories I Anatomic Pathology Supervisor I Headquarters,
Jeddah, KSA I Phone: +966 12 670 0099 I Mobile +966 503629832

  www.alborglaboratories.com

 

___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

[Histonet] ANP.22970 Annual Result Comparison

[Jamal Rwaihi via Histonet]

Good day colleagues 

 

I need your help in collecting the data for the bellow requirements for CAP,
is their good reference to collect the benchmark statistics for ER, PR &
Her2neu ?

 

 


ANP.22970

Annual Result Comparison



 

For immunohistochemical and FISH/ISH tests that provide independent
predictive information, the laboratory at least annually compares its
patient results with published benchmarks, and evaluates interobserver
variability among the pathologists in the laboratory.

NOTE: Individuals interpreting the assay must also have their concordance
compared with each other and this concordance should also be at least 95%.

With specific reference to estrogen and progesterone receptor studies: in
general, the overall proportion of ER-negative breast cancers (invasive and
DCIS) should not exceed 30%. The proportion is somewhat lower in
postmenopausal than premenopausal women (approximately 20% vs. 35%). The
proportion is considerably lower in well-differentiated carcinomas (<10%)
and certain special types of invasive carcinomas (<10% in lobular, tubular,
and mucinous types). The proportion of PgR-negative cases is 10-15% higher
than for ER-negative in each of these settings. Investigation is warranted
if the proportion of negative cases is significantly lower in any of these
settings.

 

 

Jamal M. Al Rowaihi

BCs, HT, Anatomic Pathology Supervisor

Al Borg Medical Laboratories

 

___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet

[Histonet] COMPETENCY ASSESSMENT for HISTOTECHNOLOGIST & CYTOTECHNOLOGIST

[Jamal Rwaihi via Histonet]

Dear Colleagues

I will be happy if someone share me the current CAP accepted form for:

COMPETENCY ASSESSMENT OF HISTOTECHNOLOGIST & CYTOTECHNOLOGIST

 

 

 

Best Regards,

 

 

Jamal M. Al Rowaihi

Al Borg Medical Laboratories I Anatomic Pathology Supervisor I Headquarters,
Jeddah, KSA I Phone: +966 12 670 0099 I Mobile +966 503629832

  www.alborglaboratories.com

 

___
Histonet mailing list
Histonet@lists.utsouthwestern.edu
http://lists.utsouthwestern.edu/mailman/listinfo/histonet